These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3480668)

  • 1. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
    Heptner G; Domschke S; Domschke W
    Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
    Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
    Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation.
    Denk H; Tappeiner G; Eckerstorfer R; Holzner JH
    Int J Cancer; 1972 Sep; 10(2):262-72. PubMed ID: 4350187
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
    Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
    Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of CA 19-9 in gastric and colorectal carcinoma.
    Safi F; Bittner R; Roscher R; Kübel R; Beger HG
    Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
    Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of serum CA125 values in patients with cancers of the digestive system.
    Haga Y; Sakamoto K; Egami H; Yoshimura R; Mori K; Akagi M
    Am J Med Sci; 1986 Jul; 292(1):30-4. PubMed ID: 3459357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P; Haglund C; Roberts PJ; Jalanko H
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract.
    Holyoke D; Reynoso G; Chu TM
    Ann Surg; 1972 Oct; 176(4):559-64. PubMed ID: 5077412
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.